Selected research
Market Analysis & Forecast
Global Adult Immune Cell Storage Services Market Analysis and Forecast 2026-2032
Market perspective
The global Adult Immune Cell Storage Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Adult Immune Cell Storage Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Adult Immune Cell Storage Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Adult Immune Cell Storage Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Adult Immune Cell Storage Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Adult Immune Cell Storage Services include Shanghai Cell Therapy Group, BGI Group, VCANBIO, CGT GLOBAL, Cordlife Group, ThermoGenesis, HealthBanks, BioLife Solutions and Sartorius, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Adult Immune Cell Storage Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Adult Immune Cell Storage Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Adult Immune Cell Storage Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Adult Immune Cell Storage Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Adult Immune Cell Storage Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Adult Immune Cell Storage Services revenue, projected growth trends, production technology, application and end-user industry.
Adult Immune Cell Storage Services Segment by Company
Shanghai Cell Therapy Group
BGI Group
VCANBIO
CGT GLOBAL
Cordlife Group
ThermoGenesis
HealthBanks
BioLife Solutions
Sartorius
CGT GLOBAL
Cordlife Group
Aeterna Health
Cell Vault
Redermis
Innovita Research
Adult Immune Cell Storage Services Segment by Type
100ml Blood Collection Volume
150ml Blood Collection Volume
200ml Blood Collection Volume
Adult Immune Cell Storage Services Segment by Application
Personal
Commercial
Adult Immune Cell Storage Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adult Immune Cell Storage Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Adult Immune Cell Storage Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adult Immune Cell Storage Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Adult Immune Cell Storage Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Adult Immune Cell Storage Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Adult Immune Cell Storage Services revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 100ml Blood Collection Volume
- 150ml Blood Collection Volume
- 200ml Blood Collection Volume
Applications
- Personal
- Commercial
Companies covered
- Shanghai Cell Therapy Group
- BGI Group
- VCANBIO
- CGT GLOBAL
- Cordlife Group
- ThermoGenesis
- HealthBanks
- BioLife Solutions
- Sartorius
- CGT GLOBAL
- Cordlife Group
- Aeterna Health
- Cell Vault
- Redermis
- Innovita Research
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Adult Immune Cell Storage Services Market by Type
- 1.2.1 Global Adult Immune Cell Storage Services Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 100ml Blood Collection Volume
- 1.2.3 150ml Blood Collection Volume
- 1.2.4 200ml Blood Collection Volume
- 1.3 Adult Immune Cell Storage Services Market by Application
- 1.3.1 Global Adult Immune Cell Storage Services Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Personal
- 1.3.3 Commercial
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Adult Immune Cell Storage Services Market Dynamics
- 2.1 Adult Immune Cell Storage Services Industry Trends
- 2.2 Adult Immune Cell Storage Services Industry Drivers
- 2.3 Adult Immune Cell Storage Services Industry Opportunities and Challenges
- 2.4 Adult Immune Cell Storage Services Industry Restraints
3 Global Growth Perspective
- 3.1 Global Adult Immune Cell Storage Services Market Perspective (2021-2032)
- 3.2 Global Adult Immune Cell Storage Services Growth Trends by Region
- 3.2.1 Global Adult Immune Cell Storage Services Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Adult Immune Cell Storage Services Market Size by Region (2021-2026)
- 3.2.3 Global Adult Immune Cell Storage Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Adult Immune Cell Storage Services Revenue by Players
- 4.1.1 Global Adult Immune Cell Storage Services Revenue by Players (2021-2026)
- 4.1.2 Global Adult Immune Cell Storage Services Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Adult Immune Cell Storage Services Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Adult Immune Cell Storage Services Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Adult Immune Cell Storage Services Key Players Headquarters & Area Served
- 4.4 Global Adult Immune Cell Storage Services Players, Product Type & Application
- 4.5 Global Adult Immune Cell Storage Services Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Adult Immune Cell Storage Services Market CR5 and HHI
- 4.6.3 2025 Adult Immune Cell Storage Services Tier 1, Tier 2, and Tier 3
5 Adult Immune Cell Storage Services Market Size by Type
- 5.1 Global Adult Immune Cell Storage Services Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Adult Immune Cell Storage Services Revenue by Type (2021-2032)
- 5.3 Global Adult Immune Cell Storage Services Revenue Market Share by Type (2021-2032)
6 Adult Immune Cell Storage Services Market Size by Application
- 6.1 Global Adult Immune Cell Storage Services Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Adult Immune Cell Storage Services Revenue by Application (2021-2032)
- 6.3 Global Adult Immune Cell Storage Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Shanghai Cell Therapy Group
- 7.1.1 Shanghai Cell Therapy Group Company Information
- 7.1.2 Shanghai Cell Therapy Group Business Overview
- 7.1.3 Shanghai Cell Therapy Group Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 7.1.4 Shanghai Cell Therapy Group Adult Immune Cell Storage Services Product Portfolio
- 7.1.5 Shanghai Cell Therapy Group Recent Developments
- 7.2 BGI Group
- 7.2.1 BGI Group Company Information
- 7.2.2 BGI Group Business Overview
- 7.2.3 BGI Group Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 7.2.4 BGI Group Adult Immune Cell Storage Services Product Portfolio
- 7.2.5 BGI Group Recent Developments
- 7.3 VCANBIO
- 7.3.1 VCANBIO Company Information
- 7.3.2 VCANBIO Business Overview
- 7.3.3 VCANBIO Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 7.3.4 VCANBIO Adult Immune Cell Storage Services Product Portfolio
- 7.3.5 VCANBIO Recent Developments
- 7.4 CGT GLOBAL
- 7.4.1 CGT GLOBAL Company Information
- 7.4.2 CGT GLOBAL Business Overview
- 7.4.3 CGT GLOBAL Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 7.4.4 CGT GLOBAL Adult Immune Cell Storage Services Product Portfolio
- 7.4.5 CGT GLOBAL Recent Developments
- 7.5 Cordlife Group
- 7.5.1 Cordlife Group Company Information
- 7.5.2 Cordlife Group Business Overview
- 7.5.3 Cordlife Group Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 7.5.4 Cordlife Group Adult Immune Cell Storage Services Product Portfolio
- 7.5.5 Cordlife Group Recent Developments
- 7.6 ThermoGenesis
- 7.6.1 ThermoGenesis Company Information
- 7.6.2 ThermoGenesis Business Overview
- 7.6.3 ThermoGenesis Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 7.6.4 ThermoGenesis Adult Immune Cell Storage Services Product Portfolio
- 7.6.5 ThermoGenesis Recent Developments
- 7.7 HealthBanks
- 7.7.1 HealthBanks Company Information
- 7.7.2 HealthBanks Business Overview
- 7.7.3 HealthBanks Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 7.7.4 HealthBanks Adult Immune Cell Storage Services Product Portfolio
- 7.7.5 HealthBanks Recent Developments
- 7.8 BioLife Solutions
- 7.8.1 BioLife Solutions Company Information
- 7.8.2 BioLife Solutions Business Overview
- 7.8.3 BioLife Solutions Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 7.8.4 BioLife Solutions Adult Immune Cell Storage Services Product Portfolio
- 7.8.5 BioLife Solutions Recent Developments
- 7.9 Sartorius
- 7.9.1 Sartorius Company Information
- 7.9.2 Sartorius Business Overview
- 7.9.3 Sartorius Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 7.9.4 Sartorius Adult Immune Cell Storage Services Product Portfolio
- 7.9.5 Sartorius Recent Developments
- 7.10 CGT GLOBAL
- 7.10.1 CGT GLOBAL Company Information
- 7.10.2 CGT GLOBAL Business Overview
- 7.10.3 CGT GLOBAL Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 7.10.4 CGT GLOBAL Adult Immune Cell Storage Services Product Portfolio
- 7.10.5 CGT GLOBAL Recent Developments
- 7.11 Cordlife Group
- 7.11.1 Cordlife Group Company Information
- 7.11.2 Cordlife Group Business Overview
- 7.11.3 Cordlife Group Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 7.11.4 Cordlife Group Adult Immune Cell Storage Services Product Portfolio
- 7.11.5 Cordlife Group Recent Developments
- 7.12 Aeterna Health
- 7.12.1 Aeterna Health Company Information
- 7.12.2 Aeterna Health Business Overview
- 7.12.3 Aeterna Health Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 7.12.4 Aeterna Health Adult Immune Cell Storage Services Product Portfolio
- 7.12.5 Aeterna Health Recent Developments
- 7.13 Cell Vault
- 7.13.1 Cell Vault Company Information
- 7.13.2 Cell Vault Business Overview
- 7.13.3 Cell Vault Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 7.13.4 Cell Vault Adult Immune Cell Storage Services Product Portfolio
- 7.13.5 Cell Vault Recent Developments
- 7.14 Redermis
- 7.14.1 Redermis Company Information
- 7.14.2 Redermis Business Overview
- 7.14.3 Redermis Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 7.14.4 Redermis Adult Immune Cell Storage Services Product Portfolio
- 7.14.5 Redermis Recent Developments
- 7.15 Innovita Research
- 7.15.1 Innovita Research Company Information
- 7.15.2 Innovita Research Business Overview
- 7.15.3 Innovita Research Adult Immune Cell Storage Services Revenue and Gross Margin (2021-2026)
- 7.15.4 Innovita Research Adult Immune Cell Storage Services Product Portfolio
- 7.15.5 Innovita Research Recent Developments
8 North America
- 8.1 North America Adult Immune Cell Storage Services Revenue (2021-2032)
- 8.2 North America Adult Immune Cell Storage Services Revenue by Type (2021-2032)
- 8.2.1 North America Adult Immune Cell Storage Services Revenue by Type (2021-2026)
- 8.2.2 North America Adult Immune Cell Storage Services Revenue by Type (2027-2032)
- 8.3 North America Adult Immune Cell Storage Services Revenue Share by Type (2021-2032)
- 8.4 North America Adult Immune Cell Storage Services Revenue by Application (2021-2032)
- 8.4.1 North America Adult Immune Cell Storage Services Revenue by Application (2021-2026)
- 8.4.2 North America Adult Immune Cell Storage Services Revenue by Application (2027-2032)
- 8.5 North America Adult Immune Cell Storage Services Revenue Share by Application (2021-2032)
- 8.6 North America Adult Immune Cell Storage Services Revenue by Country
- 8.6.1 North America Adult Immune Cell Storage Services Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Adult Immune Cell Storage Services Revenue by Country (2021-2026)
- 8.6.3 North America Adult Immune Cell Storage Services Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Adult Immune Cell Storage Services Revenue (2021-2032)
- 9.2 Europe Adult Immune Cell Storage Services Revenue by Type (2021-2032)
- 9.2.1 Europe Adult Immune Cell Storage Services Revenue by Type (2021-2026)
- 9.2.2 Europe Adult Immune Cell Storage Services Revenue by Type (2027-2032)
- 9.3 Europe Adult Immune Cell Storage Services Revenue Share by Type (2021-2032)
- 9.4 Europe Adult Immune Cell Storage Services Revenue by Application (2021-2032)
- 9.4.1 Europe Adult Immune Cell Storage Services Revenue by Application (2021-2026)
- 9.4.2 Europe Adult Immune Cell Storage Services Revenue by Application (2027-2032)
- 9.5 Europe Adult Immune Cell Storage Services Revenue Share by Application (2021-2032)
- 9.6 Europe Adult Immune Cell Storage Services Revenue by Country
- 9.6.1 Europe Adult Immune Cell Storage Services Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Adult Immune Cell Storage Services Revenue by Country (2021-2026)
- 9.6.3 Europe Adult Immune Cell Storage Services Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Adult Immune Cell Storage Services Revenue (2021-2032)
- 10.2 China Adult Immune Cell Storage Services Revenue by Type (2021-2032)
- 10.2.1 China Adult Immune Cell Storage Services Revenue by Type (2021-2026)
- 10.2.2 China Adult Immune Cell Storage Services Revenue by Type (2027-2032)
- 10.3 China Adult Immune Cell Storage Services Revenue Share by Type (2021-2032)
- 10.4 China Adult Immune Cell Storage Services Revenue by Application (2021-2032)
- 10.4.1 China Adult Immune Cell Storage Services Revenue by Application (2021-2026)
- 10.4.2 China Adult Immune Cell Storage Services Revenue by Application (2027-2032)
- 10.5 China Adult Immune Cell Storage Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Adult Immune Cell Storage Services Revenue (2021-2032)
- 11.2 Asia Adult Immune Cell Storage Services Revenue by Type (2021-2032)
- 11.2.1 Asia Adult Immune Cell Storage Services Revenue by Type (2021-2026)
- 11.2.2 Asia Adult Immune Cell Storage Services Revenue by Type (2027-2032)
- 11.3 Asia Adult Immune Cell Storage Services Revenue Share by Type (2021-2032)
- 11.4 Asia Adult Immune Cell Storage Services Revenue by Application (2021-2032)
- 11.4.1 Asia Adult Immune Cell Storage Services Revenue by Application (2021-2026)
- 11.4.2 Asia Adult Immune Cell Storage Services Revenue by Application (2027-2032)
- 11.5 Asia Adult Immune Cell Storage Services Revenue Share by Application (2021-2032)
- 11.6 Asia Adult Immune Cell Storage Services Revenue by Country
- 11.6.1 Asia Adult Immune Cell Storage Services Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Adult Immune Cell Storage Services Revenue by Country (2021-2026)
- 11.6.3 Asia Adult Immune Cell Storage Services Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Adult Immune Cell Storage Services Revenue (2021-2032)
- 12.2 SAMEA Adult Immune Cell Storage Services Revenue by Type (2021-2032)
- 12.2.1 SAMEA Adult Immune Cell Storage Services Revenue by Type (2021-2026)
- 12.2.2 SAMEA Adult Immune Cell Storage Services Revenue by Type (2027-2032)
- 12.3 SAMEA Adult Immune Cell Storage Services Revenue Share by Type (2021-2032)
- 12.4 SAMEA Adult Immune Cell Storage Services Revenue by Application (2021-2032)
- 12.4.1 SAMEA Adult Immune Cell Storage Services Revenue by Application (2021-2026)
- 12.4.2 SAMEA Adult Immune Cell Storage Services Revenue by Application (2027-2032)
- 12.5 SAMEA Adult Immune Cell Storage Services Revenue Share by Application (2021-2032)
- 12.6 SAMEA Adult Immune Cell Storage Services Revenue by Country
- 12.6.1 SAMEA Adult Immune Cell Storage Services Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Adult Immune Cell Storage Services Revenue by Country (2021-2026)
- 12.6.3 SAMEA Adult Immune Cell Storage Services Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst